Acadian Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-21,933
| Closed | -$394K | – | 1961 |
|
|
2017
Q4 | $394K | Buy |
+21,933
| New | +$270K | ﹤0.01% | 842 |
|
|
2017
Q2 | – | Sell |
-129,510
| Closed | -$1.43M | – | 1724 |
|
|
2017
Q1 | $1.43M | Sell |
129,510
-202,562
| -61% | -$2.35M | 0.01% | 703 |
|
|
2016
Q4 | $4.5M | Buy |
332,072
+75,050
| +29% | +$1.05M | 0.02% | 435 |
|
|
2016
Q3 | $3.17M | Sell |
257,022
-780,350
| -75% | -$9.2M | 0.02% | 442 |
|
|
2016
Q2 | $11.4M | Sell |
1,037,372
-582,018
| -36% | -$6.51M | 0.06% | 250 |
|
|
2016
Q1 | $17.7M | Sell |
1,619,390
-229,434
| -12% | -$2.9M | 0.09% | 208 |
|
|
2015
Q4 | $32M | Buy |
1,848,824
+214,305
| +13% | +$3.84M | 0.17% | 150 |
|
|
2015
Q3 | $32.5M | Buy |
1,634,519
+905,313
| +124% | +$20.8M | 0.18% | 145 |
|
|
2015
Q2 | $12M | Buy |
729,206
+450,405
| +162% | +$7.81M | 0.06% | 256 |
|
|
2015
Q1 | $4.34M | Buy |
278,801
+19,813
| +8% | +$307K | 0.02% | 414 |
|
|
2014
Q4 | $3.7M | Buy |
258,988
+58,105
| +29% | +$614K | 0.02% | 447 |
|
|
2014
Q3 | $1.31M | Sell |
200,883
-42,304
| -17% | -$281K | 0.01% | 540 |
|
|
2014
Q2 | $1.68M | Buy |
243,187
+38,866
| +19% | +$275K | 0.01% | 529 |
|
|
2014
Q1 | $1.46M | Buy |
204,321
+154,781
| +312% | +$1.32M | 0.01% | 529 |
|
|
2013
Q4 | $465K | Buy |
+49,540
| New | +$353K | ﹤0.01% | 701 |
|
|
2013
Q3 | – | Sell |
-653
| Closed | -$4K | – | 1078 |
|
|
2013
Q2 | $4K | Buy |
+653
| New | +$5.18K | ﹤0.01% | 876 |
|
Other funds holding SCMP
Acadian Asset Management's SCMP Position: Q1 2018 in Review
Acadian Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 21,933 shares — an estimated $394K sold.
Acadian Asset Management first reported a position in SCMP in Q2 2013 and held it in 16 quarters. The position peaked at $32.5M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Acadian Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Acadian Asset Management sold 21,933 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $394K.
- Acadian Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
- Acadian Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $32.5M in Q3 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Acadian Asset Management's 13F filing for Q1 2018, filed 12 Apr 2018.